Table 2. Coexpression profiles of CD133, galectin-3 and β-catenin in 197 patients with lung cancer was examined using immunohistochemistry.
| Total | Gal-3 | p-value | Total | Gal-3/β-cat coexpression | p-value | |||
|---|---|---|---|---|---|---|---|---|
| (n = 197) | Low | High | (n = 197) | Low | High | |||
| CD133 | < 0.001 | < 0.001 | ||||||
| Negative | 100 | 56 | 44 | 100 | 80 | 20 | ||
| Positive | 97 | 13 | 84 | 97 | 11 | 86 | ||
Notes: The expression levels of galectin-3 were categorized as low or high in relation to the median value of the assigned score. The p-value based on χ2 test statistic was calculated. Gal-3: galectin-3; β-cat: β-catenin.